Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years

NCT01193400 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Clofarabine
DRUG: Cytarabine

Sponsor

PETHEMA Foundation

Collaborators

[object Object]